Page last updated: 2024-10-27

gabapentin and Hepatorenal Syndrome

gabapentin has been researched along with Hepatorenal Syndrome in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Hepatorenal Syndrome: Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.

Research Excerpts

ExcerptRelevanceReference
"Pain management in patients with liver cirrhosis is a real challenge and is often inadequate due to a lack of therapeutic efficacy or the high incidence of adverse effects."2.50[Pain management in patients with liver cirrhosis]. ( Moreno, LA; Ojeda, A, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ojeda, A1
Moreno, LA1

Reviews

1 review available for gabapentin and Hepatorenal Syndrome

ArticleYear
[Pain management in patients with liver cirrhosis].
    Gastroenterologia y hepatologia, 2014, Volume: 37, Issue:1

    Topics: Acetaminophen; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therap

2014